Rep. Pascrell Supports Withdrawn FDA Emergency Use Authorization of Unproven COVID-19 Drugs
June 16, 2020
June 16, 2020
WASHINGTON, June 16 -- Rep. Bill Pascrell Jr., D-New Jersey, issued the following news release:
U.S. Rep. Bill Pascrell, Jr. praised a decision by the U.S. Food and Drug Administration (FDA) withdrawing its emergency use authorization of the two controversial and unproven treatments hydroxychloroquine and chloroquine for use against COVID-19 infections.
"This is the right decision and well overdue," said Rep. Pascrell, a vocal critic of broader politicization . . .
U.S. Rep. Bill Pascrell, Jr. praised a decision by the U.S. Food and Drug Administration (FDA) withdrawing its emergency use authorization of the two controversial and unproven treatments hydroxychloroquine and chloroquine for use against COVID-19 infections.
"This is the right decision and well overdue," said Rep. Pascrell, a vocal critic of broader politicization . . .